<DOC>
	<DOCNO>NCT00737126</DOCNO>
	<brief_summary>The development diabetic nephropathy link several genetic polymorphism , include related homocysteine metabolism methylenetetrahydrofolate reductase ( MTHFR ) cystathionine-beta-synthase gene . Such alteration associate hyperhomocysteinemia , know independent risk factor development endothelial dysfunction cardiovascular disease . In Mexican population high prevalence C677T MTHFR mutation . The investigator perform study evaluate prevalence polymorphism type 2 diabetic patient diabetic nephropathy compare type 2 diabetic patient without nephropathy , besides evaluate relationship hyperhomocysteinemia endothelial dysfunction microalbuminuria administration folic acid . We propose endothelial dysfunction cause hyperhomocysteinemia could reverse administration folic acid .</brief_summary>
	<brief_title>The Effect Folic Acid Administration Progression Microalbuminuria</brief_title>
	<detailed_description />
	<mesh_term>Kidney Diseases</mesh_term>
	<mesh_term>Diabetic Nephropathies</mesh_term>
	<mesh_term>Hyperhomocysteinemia</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<mesh_term>Vitamin B Complex</mesh_term>
	<criteria>Type 2 diabetes mellitus patient 5 15 year diagnosis Microalbuminuria ( define urinary albumin/creatinine ratio 30 300 mg/g ) A1c le 9 % last year Acute diabetic complication A1c great 9 % last year Acute infectious process Hepatic disease Thyroid disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Diabetic nephropathy</keyword>
	<keyword>Hyperhomocysteinemia</keyword>
	<keyword>Folic acid</keyword>
	<keyword>Endothelial dysfunction</keyword>
</DOC>